Comments
Loading...

Yuexiu REIT

YUXXFOTC
Logo brought to you by Benzinga Data
$0.1315
At close: Nov 14, 3:36 PM EDT

Yuexiu REIT (OTC:YUXXF) Stock Quotes, Forecast and News Summary

Yuexiu REIT Stock (OTC: YUXXF) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.0 / 327.00
Day Range- - -
52 Wk Range0.13 - 0.14
Market Cap$666.55M
P/E Ratio43.80
Dividend Yield7.09%
ExchangeOTC
RSI
0
Short Interest-
Days to Cover999.99

Recent News

No news found

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Open-
Close-
Volume / Avg.0 / 327.00
Day Range- - -
52 Wk Range0.13 - 0.14
Market Cap$666.55M
P/E Ratio43.80
Dividend Yield7.09%
ExchangeOTC
RSI
0
Short Interest-
Days to Cover999.99

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
YUXXF

FAQ

Q

How do I buy Yuexiu REIT (YUXXF) stock?

A

You can purchase shares of Yuexiu REIT (OTC:YUXXF) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Yuexiu REIT (YUXXF) competitors?

A

There are no as such competitors for Yuexiu REIT.

Q

What is the forecast, or price target, for Yuexiu REIT (YUXXF) stock?

A

There is no analysis for Yuexiu REIT to provide a consensus price target.

Q

What is the current price for Yuexiu REIT (YUXXF)?

A

The stock price for Yuexiu REIT (OTC: YUXXF) is $0.13145 last updated November 14, 2024 at 3:36 PM EST.

Q

Does Yuexiu REIT (YUXXF) pay a dividend?

A

There are no upcoming dividends for Yuexiu REIT.

Q

When is Yuexiu REIT (OTC:YUXXF) reporting earnings?

A

Yuexiu REIT does not have any upcoming earnings scheduled.

Q

Is Yuexiu REIT (YUXXF) going to split?

A

There is no upcoming split for Yuexiu REIT.

Q

What sector and industry does Yuexiu REIT (YUXXF) operate in?

A

Yuexiu REIT is in the Real Estate sector and REIT—Office industry. They are listed on the OTC.